We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation.
- Authors
Jin-liang Peng; Yong-gang Zhao; Jun-hua Mai; Wen-ka Pang; Wei Guo; Guang-ming Chen; Guo-yu Mo; Gui-rong Rao; Yu-hong Xu
- Abstract
Aim: To explore the potential of electroporation (EP)-mediated hepatitis B virus (HBV) DNA vaccination for the treatment of chronic HBV infection. Methods: BALB/c mice were vaccinated with HBV DNA vaccine encoding for the HBV preS2-S antigen, combined with or without EP. HBV surface antigen expression plasmid was administered into mice liver via a hydrodynamic injection to mimic HBV infection. The clearance of antigen in the serum and liver was detected by ELISA assay and immunohistochemical staining. The histopathology of the liver tissues was examined by HE staining and serum alanine aminotransferase assay. Results: The immunogenicity of HBV DNA vaccine encoding for the HBV preS2-S antigen can be improved by EP-mediated vaccine delivery. The elicited immune responses can indeed reduce the expression of HBV surface antigen (HBsAg) in hepatocytes of the mouse model that was transfected to express HBsAg using the hydrodynamic injection method. The antigen clearance process did not cause significant toxicity to liver tissue, suggesting a non-cytolytic mechanism. Conclusion: The EP-aided DNA vaccination may have potential in mediating viral clearance in chronic hepatitis B patients.
- Publication
Acta Pharmacologica Sinica, 2007, Vol 28, Issue 7, p1024
- ISSN
1671-4083
- Publication type
Academic Journal
- DOI
10.1111/j.1745-7254.2007.00591.x